Cardiosense
Chicago, US · Founded 2020 · Delaware corporation · 38 employees on LinkedIn · 8 known investors
Find your way into Cardiosense
1,681 people in our graph share verified history with the Cardiosense team — schools, employers, funds. One of them is your warm intro.
Chris Bischoffunlockedknows Eric Meizlish · together at Goldman Sachs (overlapped)
.jpg)
×4knows the team · via Stanford University
knows the team · via Yale University
×2knows the team · via Georgia Institute of Technology
knows the team · via Hopkins School
knows the team · via Goldman Sachs
Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management. Its FDA De Novo-cleared platform supports pressure-guided heart failure management for clinicians across hospital and home care settings.
Founders & leadership
AC
Andrew CarekinCo-founder, Chief Technical Officer
AG
Amit GuptainCo-founder, AdvisorHe co-founded the company in 2020 and served as its CEO before moving into the Chief Strategy Officer role in 2025. He previously spent nearly a decade at Ishi Systems, advancing from product manager to Director of Product, Analytics, and earlier held roles at BioXcel Corporation and ABB Robotics.
ME
Mozziyar EtemadiCo-founder, Head of AI
OI
Omer Inan, PhDinChief Scientific Officer, Co-Founder, and Board MemberHe is the Linda J. and Mark C. Smith Chaired Professor of Electrical and Computer Engineering at Georgia Tech, where he also serves as Associate Chair for Entrepreneurship and Strategic Initiatives and as a Regents Entrepreneur, having joined the faculty in 2013. In addition to co-founding Cardiosense and serving on its board, he is Chief Scientific Officer at Biozen.
AC
Andrew Carek, PhDinCo-Founder, CTOBefore co-founding the company in 2020, he was a postdoctoral researcher at Northwestern University's Feinberg School of Medicine and completed a research internship at Microsoft.
EM
Eric Meizlishin𝕏Chief Executive OfficerHe previously served as CEO of BioProcure and Prendio, and spent nearly a decade at GHX, where he co-founded Lumere and served as its President and Chief Strategy Officer before moving into strategy and corporate development leadership roles. Earlier in his career he was a long/short equity investor at Citadel and interned at the Yale University Investments Office.
JD
John D. MartininChief Medical Officer
AA
Arezou AzarinChief Regulatory & Compliance Officer
Board
JT
DG
JT
Jeffrey TrostBoard director
Investors · 8
BayMed Venture PartnersSan Francisco
Broadview VenturesBoston
Cross-Border Impact VenturesToronto · $2M – $10M
Laerdal Million Lives FundSan Francisco · $1M – $5M
OSF VenturesPeoria
Portal InnovationsChicago
Hatteras Venture Partnersreported · 3 sourcesResearch Triangle · $500K – $4M
Also in the syndicate · 1
UnityPoint Health Ventures
Funding
SEC filings, press & company announcements$35.2M disclosed across 2 of 3 rounds · 2022–2026
- Undisclosed amountSeries AJan 2026
Broadview Ventures (lead), Hatteras Venture Partners (lead), Laerdal Million Lives Fund, OSF Ventures, Portal Innovations, UnityPoint Health Ventures
Source ↗
▶$26.1MraisedAug 2026 · 30 investors · Other Health CareRule 506(b)
▶$26.1MraisedAug 2026 · 30 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric MeizlishExecutive Officer, Director
- Andrew Michael CarekExecutive Officer
- Daniel GottliebDirector
- Bimal ShahDirector
- Jeffrey TrostDirector
- Lauren Pierce FlickingerDirector
- Omer Tolga InanExecutive Officer, Director
- Offering amount
- $42M
- Amount sold
- $26.1M
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.1MraisedDec 2022 · 28 investors · OtherRule 506(b)
▶$9.1MraisedDec 2022 · 28 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jeff TerrellDirector
- Omer Tolga InanDirector
- Amit K. GuptaExecutive Officer, Director
- Andrew Michael CarekExecutive Officer
- Daniel GottliebDirector
- Offering amount
- $17.7M
- Amount sold
- $9.1M
- Minimum investment
- $20K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlap
Rf Surgical43 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Topera37 shared keywordsAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.
AliveCor34 shared keywordsAliveCor develops digital health solutions focused on cardiovascular care, serving employers and healthcare payers seeking enterprise heart health platforms.
Digital32 shared keywordsDigital.Health is a clinician-curated discovery platform where clinicians, health systems, and consumers find, compare, and select digital health solutions. It offers structured company and product listings that feed its comparison engine, recommendation system, and AI-enabled search for buyers in active evaluation.
Boston Scientific25 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Cardiac Insight Inc.18 shared keywordsCardiac Insight develops handheld and wearable ECG devices for cardiac diagnostics, including the Cardea 20/20 for athlete heart screening and the Cardea SOLO for 7-day ambulatory monitoring. The company serves healthcare providers and patients seeking reliable electrocardiogram analysis and cardiac evaluation.
Companies competing with Cardiosense for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Cardiosense do?
- Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management. Its FDA De Novo-cleared platform supports pressure-guided heart failure management for clinicians across hospital and home care settings.
- Who founded Cardiosense?
- Cardiosense was founded by Omer Inan, Andrew Carek, Amit Gupta, Mozziyar Etemadi, Omer Inan, PhD, Andrew Carek, PhD in 2020.
- Who are Cardiosense's investors?
- Cardiosense's investors include BayMed Venture Partners, Broadview Ventures, Cross-Border Impact Ventures, Laerdal Million Lives Fund, OSF Ventures, Portal Innovations, Hatteras Venture Partners.
- How much funding has Cardiosense raised?
- Cardiosense has disclosed $35.2M raised across 2 of its 3 known rounds.
- Where is Cardiosense headquartered?
- Cardiosense is headquartered in Chicago, US.